Lab M now offers full range of European Pharmacopoeia media

LAB M LOGO Neogen GreenHEYWOOD, UK, 27 January, 2016 — Lab M has enhanced its pharmacopoeia range to ensure that all media listed in the European Pharmacopoeia 8.0 volume 1 (2014) are now available in its portfolio.

Lab M offers all 17 dehydrated culture media products referenced in the European Pharmacopoeia (EP), and each of the 17 has been formulated to and performance tested by the requirements specified within the pharmacopoeia. The use of Lab M’s products enables laboratories to comply to the EP standard, which is harmonised with the equivalent chapters of the United States (USP) and Japanese (JP) pharmacopoeias.

“We’re very excited to offer these 17 products as they expand our presence within the pharmaceutical industry, demonstrating the capabilities of Lab M and the breadth of our portfolio,” said Ian Morris, Lab M’s general manager. “From our founding in 1971, Lab M has been dedicated to the most demanding quality standards in the industry. The development of our expanded range of products is an example of that dedication, as each was formulated in accordance with the requirements of the harmonised chapters of the pharmacopoeia.”

The 17 products within the EP range includes media for sterility testing, for the examination of nonsterile products for specific organisms, and support media for control culture cultivation inoculum preparation.

Lab M’s extensive range of microbiological culture media, supplements, immunomagnetic separation techniques and proficiency testing systems are used in laboratories around the world. In November 2015, the quality control laboratory of Lab M’s facilities in Heywood, UK, was granted ISO 17025:2005 accreditation by the United Kingdom Accreditation Service (UKAS).

Lab M specialises in the development, manufacture and supply of microbiological culture media and related products. The company is also an established supplier of bulk peptones and other raw materials used in a number of applications, including the manufacture of vaccines. Lab M operates from purpose-built facilities in the UK and is certified in accordance with ISO 9001:2008 and 13485:2003; products for the clinical market are supplied in compliance with the European IVD directive and carry the CE mark. www.labm.com.

For more information, click here.

Comments are closed.